Vandana S. Nikam

Employment

• Piramal Enterprises Ltd Scientific officer
  2000 - 2003

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Angiotensin converting enzyme 2 level and its significance in COVID‐19 and other diseases patients
  European Journal of Clinical Investigation 2023 DOI: 10.1111/eci.13891
  +Save
• Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system
  Nature Communications 2022 DOI: 10.1038/s41467-022-33458-8
  +Save
• Silk fibroin nanofibers enhance cell adhesion of blood-derived fibroblast-like cells: A potential application for wound healing
  Indian Journal of Pharmacology 2020 DOI: 10.4103/ijp.IJP_609_19
  +Save
• Zebrafish: An emerging whole-organism screening tool in safety pharmacology
  Indian Journal of Pharmacology 2020 DOI: 10.4103/ijp.IJP-482-19
  +Save
• Vaccines as Immunotherapy
  Immunotherapy – A Novel Facet of Modern Therapeutics 2020 DOI: 10.1007/978-981-15-9038-2_3
  +Save
• Simple, cost effective UV-VIS method for estimation of Elvitegravir (EVG) in pure and dosage form by QbD approach and in presence of mammalian plasma
  Indian Drugs 2020
  +Save
• Potential of low molecular weight natural polysaccharides for colon targeted formulation and its evaluation in human by Gamma Scintigraphy
  Journal of Pharmaceutical Investigation 2020 DOI: 10.1007/s40005-019-00447-x
  +Save
• Immunotherapy in Neurodegenerative Disorders
  Immunotherapy – A Novel Facet of Modern Therapeutics 2020 DOI: 10.1007/978-981-15-9038-2_5
  +Save
• Immunotherapy - A Novel Facet of Modern Therapeutics
  Immunotherapy – A Novel Facet of Modern Therapeutics 2020 DOI: 10.1007/978-981-15-9038-2
  +Save
• Future Immunotherapy Challenges and Perspectives
  Immunotherapy – A Novel Facet of Modern Therapeutics 2020 DOI: 10.1007/978-981-15-9038-2_11
  +Save